{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:28:07Z","timestamp":1768836487570,"version":"3.49.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T00:00:00Z","timestamp":1340236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12016-012-8318-y","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T02:58:46Z","timestamp":1352429926000},"page":"281-291","source":"Crossref","is-referenced-by-count":40,"title":["To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra"],"prefix":"10.1007","volume":"43","author":[{"given":"Rita A.","family":"Moura","sequence":"first","affiliation":[]},{"given":"Luis","family":"Graca","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o E.","family":"Fonseca","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,6,21]]},"reference":[{"key":"8318_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094\u20131108","journal-title":"Lancet"},{"key":"8318_CR2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/keq029","volume":"49","author":"RA Moura","year":"2010","unstructured":"Moura RA, Weinmann P, Pereira PA et al (2010) Alterations on peripheral blood B-cell subpopulations in very early arthritis patients. Rheumatology (Oxford) 49:1082\u20131092","journal-title":"Rheumatology (Oxford)"},{"key":"8318_CR3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/rheumatology\/keq338","volume":"50","author":"RA Moura","year":"2011","unstructured":"Moura RA, Cascao R, Perpetuo I et al (2011) Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. Rheumatology (Oxford) 50:278\u2013282","journal-title":"Rheumatology (Oxford)"},{"key":"8318_CR4","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1186\/ar3168","volume":"12","author":"R Cascao","year":"2010","unstructured":"Cascao R, Moura RA, Perpetuo I et al (2010) Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther 12:R196","journal-title":"Arthritis Res Ther"},{"key":"8318_CR5","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1136\/ard.2010.131326","volume":"69","author":"I Torre de la","year":"2010","unstructured":"de la Torre I, Moura RA, Leandro MJ, Edwards J, Cambridge G (2010) B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy. Ann Rheum Dis 69:2181\u20132188","journal-title":"Ann Rheum Dis"},{"key":"8318_CR6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","volume":"17","author":"E Waaler","year":"1940","unstructured":"Waaler E (1940) On the occurrence of a factor in human serum activating the specific agglutination of sheep red corpuscles. Acta Pathol Microbiol Scand 17:172\u2013188","journal-title":"Acta Pathol Microbiol Scand"},{"key":"8318_CR7","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/art.10472","volume":"46","author":"H Burkhardt","year":"2002","unstructured":"Burkhardt H, Koller T, Engstrom A et al (2002) Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 46:2339\u20132348","journal-title":"Arthritis Rheum"},{"key":"8318_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/ard.2004.025502","volume":"64","author":"M Schaller","year":"2005","unstructured":"Schaller M, Stohl W, Tan SM, Benoit VM, Hilbert DM, Ditzel HJ (2005) Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis 64:743\u2013749","journal-title":"Ann Rheum Dis"},{"key":"8318_CR9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/32.3.199","volume":"32","author":"W Hassfeld","year":"1993","unstructured":"Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS (1993) Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol 32:199\u2013203","journal-title":"Br J Rheumatol"},{"key":"8318_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273\u2013281","journal-title":"J Clin Invest"},{"key":"8318_CR11","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar2954","volume":"12","author":"A Angyal","year":"2010","unstructured":"Angyal A, Egelston C, Kobezda T et al (2010) Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints. Arthritis Res Ther 12:R44","journal-title":"Arthritis Res Ther"},{"key":"8318_CR12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/art.1780280704","volume":"28","author":"RM Wernick","year":"1985","unstructured":"Wernick RM, Lipsky PE, Marban-Arcos E, Maliakkal JJ, Edelbaum D, Ziff M (1985) IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum 28:742\u2013752","journal-title":"Arthritis Rheum"},{"key":"8318_CR13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/37.2.126","volume":"37","author":"JC Edwards","year":"1998","unstructured":"Edwards JC, Cambridge G (1998) Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br J Rheumatol 37:126\u2013130","journal-title":"Br J Rheumatol"},{"key":"8318_CR14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/030097498442352","volume":"27","author":"S Pai","year":"1998","unstructured":"Pai S, Pai L, Birkenfeldt R (1998) Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol 27:252\u2013256","journal-title":"Scand J Rheumatol"},{"key":"8318_CR15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI107949","volume":"55","author":"K Tanimoto","year":"1975","unstructured":"Tanimoto K, Cooper NR, Johnson JS, Vaughan JH (1975) Complement fixation by rheumatoid factor. J Clin Invest 55:437\u2013445","journal-title":"J Clin Invest"},{"key":"8318_CR16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"VP Nell","year":"2005","unstructured":"Nell VP, Machold KP, Stamm TA et al (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731\u20131736","journal-title":"Ann Rheum Dis"},{"key":"8318_CR17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/eji.1830270323","volume":"27","author":"M Borretzen","year":"1997","unstructured":"Borretzen M, Chapman C, Natvig JB, Thompson KM (1997) Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage. Eur J Immunol 27:735\u2013741","journal-title":"Eur J Immunol"},{"key":"8318_CR18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/eji.1830240808","volume":"24","author":"KM Thompson","year":"1994","unstructured":"Thompson KM, Randen I, Borretzen M, Forre O, Natvig JB (1994) Variable region gene usage of human monoclonal rheumatoid factors derived from healthy donors following immunization. Eur J Immunol 24:1771\u20131778","journal-title":"Eur J Immunol"},{"key":"8318_CR19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/03009749509095183","volume":"24","author":"T Jonsson","year":"1995","unstructured":"Jonsson T, Arinbjarnarson S, Thorsteinsson J et al (1995) Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 24:372\u2013375","journal-title":"Scand J Rheumatol"},{"key":"8318_CR20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0307-742X(21)00604-4","volume":"11","author":"M Mannik","year":"1985","unstructured":"Mannik M, Nardella FA (1985) IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis 11:551\u2013572","journal-title":"Clin Rheum Dis"},{"key":"8318_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"8318_CR22","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"8318_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"8318_CR24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E Girbal-Neuhauser","year":"1999","unstructured":"Girbal-Neuhauser E, Durieux JJ, Arnaud M et al (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585\u2013594","journal-title":"J Immunol"},{"key":"8318_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0","volume":"44","author":"CC Reparon-Schuijt","year":"2001","unstructured":"Reparon-Schuijt CC, van Esch WJ, van Kooten C et al (2001) Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 44:41\u201347","journal-title":"Arthritis Rheum"},{"key":"8318_CR26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","volume":"25","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25:1106\u20131118","journal-title":"Bioessays"},{"key":"8318_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/qjmed\/hcp165","volume":"103","author":"YW Song","year":"2010","unstructured":"Song YW, Kang EH (2010) Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM 103:139\u2013146","journal-title":"QJM"},{"key":"8318_CR28","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C Masson-Bessiere","year":"2001","unstructured":"Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al (2001) The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 166:4177\u20134184","journal-title":"J Immunol"},{"key":"8318_CR29","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar2478","volume":"10","author":"X Zhao","year":"2008","unstructured":"Zhao X, Okeke NL, Sharpe O et al (2008) Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 10:R94","journal-title":"Arthritis Res Ther"},{"key":"8318_CR30","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH Helm-van Mil van der","year":"2005","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949\u2013958","journal-title":"Arthritis Res Ther"},{"key":"8318_CR31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.20081862","volume":"206","author":"H Uysal","year":"2009","unstructured":"Uysal H, Bockermann R, Nandakumar KS et al (2009) Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 206:449\u2013462","journal-title":"J Exp Med"},{"key":"8318_CR32","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"MP Linden van der","year":"2009","unstructured":"van der Linden MP, van der Woude D, Ioan-Facsinay A et al (2009) Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum 60:2232\u20132241","journal-title":"Arthritis Rheum"},{"key":"8318_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.23148","volume":"58","author":"M Oosterhout van","year":"2008","unstructured":"van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM (2008) Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 58:53\u201360","journal-title":"Arthritis Rheum"},{"key":"8318_CR34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","volume":"67","author":"SW Syversen","year":"2008","unstructured":"Syversen SW, Gaarder PI, Goll GL et al (2008) High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 67:212\u2013217","journal-title":"Ann Rheum Dis"},{"key":"8318_CR35","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","volume":"192","author":"D Breitfeld","year":"2000","unstructured":"Breitfeld D, Ohl L, Kremmer E et al (2000) Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 192:1545\u20131552","journal-title":"J Exp Med"},{"key":"8318_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1073\/pnas.93.1.221","volume":"93","author":"AE Schroder","year":"1996","unstructured":"Schroder AE, Greiner A, Seyfert C, Berek C (1996) Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 93:221\u2013225","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8318_CR37","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4049\/jimmunol.167.2.1072","volume":"167","author":"S Takemura","year":"2001","unstructured":"Takemura S, Braun A, Crowson C et al (2001) Lymphoid neogenesis in rheumatoid synovitis. J Immunol 167:1072\u20131080","journal-title":"J Immunol"},{"key":"8318_CR38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","volume":"6","author":"F Humby","year":"2009","unstructured":"Humby F, Bombardieri M, Manzo A et al (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6:e1","journal-title":"PLoS Med"},{"key":"8318_CR39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s100510070002","volume":"18","author":"JE Fonseca","year":"2000","unstructured":"Fonseca JE, Canhao H, Resende C et al (2000) Histology of the synovial tissue: value of semiquantitative analysis for the prediction of joint erosions in rheumatoid arthritis. Clin Exp Rheumatol 18:559\u2013564","journal-title":"Clin Exp Rheumatol"},{"key":"8318_CR40","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/art.23966","volume":"58","author":"A Manzo","year":"2008","unstructured":"Manzo A, Vitolo B, Humby F et al (2008) Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum 58:3377\u20133387","journal-title":"Arthritis Rheum"},{"key":"8318_CR41","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.22439","volume":"56","author":"KW Kim","year":"2007","unstructured":"Kim KW, Cho ML, Kim HR et al (2007) Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 56:1076\u20131086","journal-title":"Arthritis Rheum"},{"key":"8318_CR42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(00)80589-0","volume":"9","author":"PD Rennert","year":"1998","unstructured":"Rennert PD, James D, Mackay F, Browning JL, Hochman PS (1998) Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9:71\u201379","journal-title":"Immunity"},{"key":"8318_CR43","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","volume":"44","author":"GS Cheema","year":"2001","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44:1313\u20131319","journal-title":"Arthritis Rheum"},{"key":"8318_CR44","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2007-03-081232","volume":"111","author":"G Badr","year":"2008","unstructured":"Badr G, Borhis G, Lefevre EA et al (2008) BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 111:2744\u20132754","journal-title":"Blood"},{"key":"8318_CR45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780310614","volume":"31","author":"FA Houssiau","year":"1988","unstructured":"Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31:784\u2013788","journal-title":"Arthritis Rheum"},{"key":"8318_CR46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","volume":"8","author":"JE Fonseca","year":"2009","unstructured":"Fonseca JE, Santos MJ, Canhao H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538\u2013542","journal-title":"Autoimmun Rev"},{"key":"8318_CR47","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","volume":"175","author":"R Ettinger","year":"2005","unstructured":"Ettinger R, Sims GP, Fairhurst AM et al (2005) IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 175:7867\u20137879","journal-title":"J Immunol"},{"key":"8318_CR48","doi-asserted-by":"crossref","unstructured":"Hickman-Brecks, C. L., Racz, J. L., Meyer, D. M., Labranche, T. P., Allen, P. M. (2010), Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun","DOI":"10.1016\/j.jaut.2010.10.007"},{"key":"8318_CR49","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.4049\/jimmunol.0903839","volume":"185","author":"D Kashiwakuma","year":"2010","unstructured":"Kashiwakuma D, Suto A, Hiramatsu Y et al (2010) B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses. J Immunol 185:2730\u20132736","journal-title":"J Immunol"},{"key":"8318_CR50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","volume":"314","author":"A Lanzavecchia","year":"1985","unstructured":"Lanzavecchia A (1985) Antigen-specific interaction between T and B cells. Nature 314:537\u2013539","journal-title":"Nature"},{"key":"8318_CR51","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/intimm\/13.12.1583","volume":"13","author":"A Rivera","year":"2001","unstructured":"Rivera A, Chen CC, Ron N, Dougherty JP, Ron Y (2001) Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol 13:1583\u20131593","journal-title":"Int Immunol"},{"key":"8318_CR52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.173.2.487","volume":"173","author":"E Roosnek","year":"1991","unstructured":"Roosnek E, Lanzavecchia A (1991) Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 173:487\u2013489","journal-title":"J Exp Med"},{"key":"8318_CR53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.177.1.109","volume":"177","author":"H Tighe","year":"1993","unstructured":"Tighe H, Chen PP, Tucker R et al (1993) Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J Exp Med 177:109\u2013118","journal-title":"J Exp Med"},{"key":"8318_CR54","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.174.6.3781","volume":"174","author":"SK O'Neill","year":"2005","unstructured":"O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, Finnegan A (2005) Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 174:3781\u20133788","journal-title":"J Immunol"},{"key":"8318_CR55","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","volume":"167","author":"S Takemura","year":"2001","unstructured":"Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167:4710\u20134718","journal-title":"J Immunol"},{"key":"8318_CR56","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.4049\/jimmunol.1101844","volume":"187","author":"KM Hamel","year":"2011","unstructured":"Hamel KM, Cao Y, Ashaye S et al (2011) B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis. J Immunol 187:4900\u20134906","journal-title":"J Immunol"},{"key":"8318_CR57","doi-asserted-by":"crossref","first-page":"e10558","DOI":"10.1371\/journal.pone.0010558","volume":"5","author":"J Duarte","year":"2010","unstructured":"Duarte J, Agua-Doce A, Oliveira VG, Fonseca JE, Graca L (2010) Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice. PLoS One 5:e10558","journal-title":"PLoS One"},{"key":"8318_CR58","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123\u20131132","journal-title":"Nat Immunol"},{"key":"8318_CR59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","volume":"50","author":"E Lubberts","year":"2004","unstructured":"Lubberts E, Koenders MI, Oppers-Walgreen B et al (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650\u2013659","journal-title":"Arthritis Rheum"},{"key":"8318_CR60","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud M, Durand JM, Buchs N et al (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963\u2013970","journal-title":"Arthritis Rheum"},{"key":"8318_CR61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ni1552","volume":"9","author":"HC Hsu","year":"2008","unstructured":"Hsu HC, Yang P, Wang J et al (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9:166\u2013175","journal-title":"Nat Immunol"},{"key":"8318_CR62","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.4049\/jimmunol.0903133","volume":"184","author":"S Xie","year":"2010","unstructured":"Xie S, Li J, Wang JH et al (2010) IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16. J Immunol 184:2289\u20132296","journal-title":"J Immunol"},{"key":"8318_CR63","doi-asserted-by":"crossref","first-page":"14993","DOI":"10.1073\/pnas.0806044105","volume":"105","author":"Q Lai Kwan Lam","year":"2008","unstructured":"Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L (2008) Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci U S A 105:14993\u201314998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8318_CR64","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","volume":"107","author":"M Mitsdoerffer","year":"2010","unstructured":"Mitsdoerffer M, Lee Y, Jager A et al (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107:14292\u201314297","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8318_CR65","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.181.1.186","volume":"181","author":"R Takagi","year":"2008","unstructured":"Takagi R, Higashi T, Hashimoto K et al (2008) B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J Immunol 181:186\u2013189","journal-title":"J Immunol"},{"key":"8318_CR66","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87:811\u2013822","journal-title":"Cell"},{"key":"8318_CR67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","volume":"10","author":"AS Korganow","year":"1999","unstructured":"Korganow AS, Ji H, Mangialaio S et al (1999) From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10:451\u2013461","journal-title":"Immunity"},{"key":"8318_CR68","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","volume":"32","author":"HJ Wu","year":"2010","unstructured":"Wu HJ, Ivanov II, Darce J et al (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32:815\u2013827","journal-title":"Immunity"},{"key":"8318_CR69","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.27729","volume":"62","author":"BR Raposo","year":"2010","unstructured":"Raposo BR, Rodrigues-Santos P, Carvalheiro H et al (2010) Monoclonal anti-CD8 therapy induces disease amelioration in the K\/BxN mouse model of spontaneous chronic polyarthritis. Arthritis Rheum 62:2953\u20132962","journal-title":"Arthritis Rheum"},{"key":"8318_CR70","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H et al (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454\u2013460","journal-title":"Nature"},{"key":"8318_CR71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2567.2001.01257.x","volume":"103","author":"M Ehinger","year":"2001","unstructured":"Ehinger M, Vestberg M, Johansson AC, Johannesson M, Svensson A, Holmdahl R (2001) Influence of CD4 or CD8 deficiency on collagen-induced arthritis. Immunology 103:291\u2013300","journal-title":"Immunology"},{"key":"8318_CR72","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2249.1998.00529.x","volume":"111","author":"L Svensson","year":"1998","unstructured":"Svensson L, Jirholt J, Holmdahl R, Jansson L (1998) B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 111:521\u2013526","journal-title":"Clin Exp Immunol"},{"key":"8318_CR73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaut.2011.05.002","volume":"37","author":"M Behrens","year":"2011","unstructured":"Behrens M, Smart M, Luckey D, Luthra H, Taneja V (2011) To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun 37:95\u2013103","journal-title":"J Autoimmun"},{"key":"8318_CR74","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000082102","volume":"8","author":"MS Cragg","year":"2005","unstructured":"Cragg MS, Walshe CA, Ivanov AO, Glennie MJ (2005) The biology of CD20 and its potential as a target for mAb therapy. Curr Dir Autoimmun 8:140\u2013174","journal-title":"Curr Dir Autoimmun"},{"key":"8318_CR75","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-Lopez AJ, White CA et al (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188\u20132195","journal-title":"Blood"},{"key":"8318_CR76","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001622-199811000-00012","volume":"10","author":"GA Leget","year":"1998","unstructured":"Leget GA, Czuczman MS (1998) Use of rituximab, the new FDA-approved antibody. Curr Opin Oncol 10:548\u2013551","journal-title":"Curr Opin Oncol"},{"key":"8318_CR77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/rheumatology\/40.2.205","volume":"40","author":"JC Edwards","year":"2001","unstructured":"Edwards JC, Cambridge G (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 40:205\u2013211","journal-title":"Rheumatology (Oxford)"},{"key":"8318_CR78","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/ard.61.10.883","volume":"61","author":"MJ Leandro","year":"2002","unstructured":"Leandro MJ, Edwards JC, Cambridge G (2002) Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 61:883\u2013888","journal-title":"Ann Rheum Dis"},{"key":"8318_CR79","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JC Edwards","year":"2004","unstructured":"Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572\u20132581","journal-title":"N Engl J Med"},{"key":"8318_CR80","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","volume":"54","author":"P Emery","year":"2006","unstructured":"Emery P, Fleischmann R, Filipowicz-Sosnowska A et al (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54:1390\u20131400","journal-title":"Arthritis Rheum"},{"key":"8318_CR81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253\u2013259","journal-title":"N Engl J Med"},{"key":"8318_CR82","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594\u20131602","journal-title":"N Engl J Med"},{"key":"8318_CR83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt ME, Keystone EC, Furst DE et al (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48:35\u201345","journal-title":"Arthritis Rheum"},{"key":"8318_CR84","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","volume":"54","author":"SB Cohen","year":"2006","unstructured":"Cohen SB, Emery P, Greenwald MW et al (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54:2793\u20132806","journal-title":"Arthritis Rheum"},{"key":"8318_CR85","doi-asserted-by":"crossref","unstructured":"Edwards, J. C., Leandro, M. J., Cambridge, G. (2004), B lymphocyte depletion therapy with rituximab in rheumatoid arthritis. Rheum Dis Clin North Am. 30, 393-403, viii","DOI":"10.1016\/j.rdc.2004.01.006"},{"key":"8318_CR86","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.23473","volume":"58","author":"P Roll","year":"2008","unstructured":"Roll P, Dorner T, Tony HP (2008) Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment. Arthritis Rheum 58:1566\u20131575","journal-title":"Arthritis Rheum"},{"key":"8318_CR87","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/rheumatology\/kep314","volume":"48","author":"L Quartuccio","year":"2009","unstructured":"Quartuccio L, Fabris M, Salvin S et al (2009) Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. Rheumatology (Oxford) 48:1557\u20131559","journal-title":"Rheumatology (Oxford)"},{"key":"8318_CR88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF03256352","volume":"14","author":"A Pyrpasopoulou","year":"2010","unstructured":"Pyrpasopoulou A, Douma S, Triantafyllou A et al (2010) Response to rituximab and timeframe to relapse in rheumatoid arthritis patients: association with B-cell markers. Mol Diagn Ther 14:43\u201348","journal-title":"Mol Diagn Ther"},{"key":"8318_CR89","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","volume":"48","author":"G Cambridge","year":"2003","unstructured":"Cambridge G, Leandro MJ, Edwards JC et al (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48:2146\u20132154","journal-title":"Arthritis Rheum"},{"key":"8318_CR90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/rheumatology\/kel148","volume":"46","author":"MJ Leandro","year":"2007","unstructured":"Leandro MJ, Cooper N, Cambridge G, Ehrenstein MR, Edwards JC (2007) Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy. Rheumatology (Oxford) 46:29\u201336","journal-title":"Rheumatology (Oxford)"},{"key":"8318_CR91","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1002\/art.22967","volume":"56","author":"YK Teng","year":"2007","unstructured":"Teng YK, Levarht EW, Hashemi M et al (2007) Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis Rheum 56:3909\u20133918","journal-title":"Arthritis Rheum"},{"key":"8318_CR92","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.21650","volume":"54","author":"G Cambridge","year":"2006","unstructured":"Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC (2006) Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum 54:723\u2013732","journal-title":"Arthritis Rheum"},{"key":"8318_CR93","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1084\/jem.186.10.1749","volume":"186","author":"A Mizoguchi","year":"1997","unstructured":"Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK (1997) Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 186:1749\u20131756","journal-title":"J Exp Med"},{"key":"8318_CR94","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","volume":"16","author":"A Mizoguchi","year":"2002","unstructured":"Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219\u2013230","journal-title":"Immunity"},{"key":"8318_CR95","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","volume":"197","author":"C Mauri","year":"2003","unstructured":"Mauri C, Gray D, Mushtaq N, Londei M (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197:489\u2013501","journal-title":"J Exp Med"},{"key":"8318_CR96","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","volume":"182","author":"PA Blair","year":"2009","unstructured":"Blair PA, Chavez-Rueda KA, Evans JG et al (2009) Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice. J Immunol 182:3492\u20133502","journal-title":"J Immunol"},{"key":"8318_CR97","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944\u2013950","journal-title":"Nat Immunol"},{"key":"8318_CR98","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/jir.2010.0020","volume":"31","author":"JH Lee","year":"2011","unstructured":"Lee JH, Noh J, Noh G, Choi WS, Cho S, Lee SS (2011) Allergen-specific transforming growth factor-beta-producing CD19+ CD5+ regulatory B-cell (Br3) responses in human late eczematous allergic reactions to cow's milk. J Interferon Cytokine Res 31:441\u2013449","journal-title":"J Interferon Cytokine Res"},{"issue":"1114\u20131124","key":"8318_CR99","first-page":"e1118","volume":"125","author":"S Amu","year":"2011","unstructured":"Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG (2011) Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 125(1114\u20131124):e1118","journal-title":"J Allergy Clin Immunol"},{"key":"8318_CR100","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","volume":"186","author":"NA Carter","year":"2011","unstructured":"Carter NA, Vasconcellos R, Rosser EC et al (2011) Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells. J Immunol 186:5569\u20135579","journal-title":"J Immunol"},{"key":"8318_CR101","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","volume":"178","author":"M Duddy","year":"2007","unstructured":"Duddy M, Niino M, Adatia F et al (2007) Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 178:6092\u20136099","journal-title":"J Immunol"},{"key":"8318_CR102","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/eji.201040673","volume":"40","author":"JD Bouaziz","year":"2010","unstructured":"Bouaziz JD, Calbo S, Maho-Vaillant M et al (2010) IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 40:2686\u20132691","journal-title":"Eur J Immunol"},{"key":"8318_CR103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Norena LY, Flores-Borja F et al (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32:129\u2013140","journal-title":"Immunity"},{"key":"8318_CR104","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2010","unstructured":"Iwata Y, Matsushita T, Horikawa M et al (2010) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117:530\u2013541","journal-title":"Blood"},{"key":"8318_CR105","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","volume":"190","author":"F Mackay","year":"1999","unstructured":"Mackay F, Woodcock SA, Lawton P et al (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697\u20131710","journal-title":"J Exp Med"},{"key":"8318_CR106","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1073\/pnas.97.7.3370","volume":"97","author":"SD Khare","year":"2000","unstructured":"Khare SD, Sarosi I, Xia XZ et al (2000) Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A 97:3370\u20133375","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8318_CR107","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.10860","volume":"48","author":"SM Tan","year":"2003","unstructured":"Tan SM, Xu D, Roschke V et al (2003) Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum 48:982\u2013992","journal-title":"Arthritis Rheum"},{"key":"8318_CR108","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.4049\/jimmunol.178.5.2872","volume":"178","author":"R Ettinger","year":"2007","unstructured":"Ettinger R, Sims GP, Robbins R et al (2007) IL-21 and BAFF\/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol 178:2872\u20132882","journal-title":"J Immunol"},{"key":"8318_CR109","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.1741","volume":"10","author":"A Doreau","year":"2009","unstructured":"Doreau A, Belot A, Bastid J et al (2009) Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10:778\u2013785","journal-title":"Nat Immunol"},{"key":"8318_CR110","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","volume":"3","author":"MB Litinskiy","year":"2002","unstructured":"Litinskiy MB, Nardelli B, Hilbert DM et al (2002) DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3:822\u2013829","journal-title":"Nat Immunol"},{"key":"8318_CR111","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2007-09-110858","volume":"111","author":"E Belnoue","year":"2008","unstructured":"Belnoue E, Pihlgren M, McGaha TL et al (2008) APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111:2755\u20132764","journal-title":"Blood"},{"key":"8318_CR112","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/03009740701286615","volume":"36","author":"K Nakajima","year":"2007","unstructured":"Nakajima K, Itoh K, Nagatani K et al (2007) Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis. Scand J Rheumatol 36:365\u2013372","journal-title":"Scand J Rheumatol"},{"key":"8318_CR113","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00296-008-0773-7","volume":"29","author":"W Dong","year":"2009","unstructured":"Dong W, Li X, Liu H, Zhu P (2009) Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis. Rheumatol Int 29:801\u2013806","journal-title":"Rheumatol Int"},{"key":"8318_CR114","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","volume":"404","author":"JA Gross","year":"2000","unstructured":"Gross JA, Johnston J, Mudri S et al (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995\u2013999","journal-title":"Nature"},{"key":"8318_CR115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1074-7613(02)00425-9","volume":"17","author":"N Kayagaki","year":"2002","unstructured":"Kayagaki N, Yan M, Seshasayee D et al (2002) BAFF\/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17:515\u2013524","journal-title":"Immunity"},{"key":"8318_CR116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.23178","volume":"58","author":"PP Tak","year":"2008","unstructured":"Tak PP, Thurlings RM, Rossier C et al (2008) Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis Rheum 58:61\u201372","journal-title":"Arthritis Rheum"},{"key":"8318_CR117","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","volume":"63","author":"R Furie","year":"2011","unstructured":"Furie R, Petri M, Zamani O et al (2011) A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum 63:3918\u20133930","journal-title":"Arthritis Rheum"},{"key":"8318_CR118","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.167.2.332","volume":"167","author":"A Muraguchi","year":"1988","unstructured":"Muraguchi A, Hirano T, Tang B et al (1988) The essential role of B cell stimulatory factor 2 (BSF-2\/IL-6) for the terminal differentiation of B cells. J Exp Med 167:332\u2013344","journal-title":"J Exp Med"},{"key":"8318_CR119","doi-asserted-by":"crossref","unstructured":"Roll, P., Muhammad, K., Schumann, M., et al. (2011), In vivo effect of the anti interleukin-6 receptor inhibitor tocilizumab on the B-cell compartment. Arthritis Rheum","DOI":"10.1002\/art.30242"},{"key":"8318_CR120","doi-asserted-by":"crossref","unstructured":"Kawashiri, S. Y., Kawakami, A., Iwamoto, N., et al. (2011), In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline. Mod Rheumatol","DOI":"10.1007\/s10165-010-0409-0"},{"key":"8318_CR121","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2010.141325","volume":"70","author":"K Muhammad","year":"2011","unstructured":"Muhammad K, Roll P, Seibold T et al (2011) Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells. Ann Rheum Dis 70:1507\u20131510","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-012-8318-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8318-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T17:47:28Z","timestamp":1687801648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-012-8318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,21]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["8318"],"URL":"https:\/\/doi.org\/10.1007\/s12016-012-8318-y","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,21]]}}}